Amarin Corporation plc
NASDAQ: AMRN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Aaron D. Berg
- Employees
- 275
- Headquarters
- Dublin, Ireland
- IPO year
- 1993
- Market cap
- $339.4M
- Website
- https://www.amarincorp.com
Loading AMRN…
Loading profile data…Frequently asked questions about AMRN
What does Amarin Corporation plc (AMRN) do?
Amarin Corporation plc is a pharmaceutical firm dedicated to the research, development, and commercialization of therapeutic solutions for cardiovascular diseases. Its operations span several international regions, including the United States, Germany, Canada, Lebanon, and the United Arab Emirates. The company's flagship product is VASCEPA, an o...
Where does AMRN trade?
Amarin Corporation plc (AMRN) trades on the NASDAQ Global Market.
What sector is AMRN in?
Amarin Corporation plc (AMRN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Amarin Corporation plc?
Aaron D. Berg is the chief executive officer of Amarin Corporation plc (AMRN).
Where is Amarin Corporation plc headquartered?
Amarin Corporation plc is headquartered in Ireland.
Does AMRN pay a dividend?
Amarin Corporation plc (AMRN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AMRN go public?
Amarin Corporation plc (AMRN) completed its initial public offering in 1993.
Is AMRN an ADR?
Yes — AMRN is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Amarin Corporation plc reporting and dividends follow the underlying issuer.